|国家科技期刊平台
首页|期刊导航|川北医学院学报|血清高敏C反应蛋白/前白蛋白比值与急性ST段抬高型心肌梗死患者PCI术后冠状动脉无复流的相关性

血清高敏C反应蛋白/前白蛋白比值与急性ST段抬高型心肌梗死患者PCI术后冠状动脉无复流的相关性OACSTPCD

Correlation between serum high-sensitivity C-reactive protein/prealbumin ratio and coronary no-reflow after PCI in patients with acute ST-segment elevation myocardial infarction

中文摘要英文摘要

目的:探讨高敏C反应蛋白/前白蛋白(hs-CRP/PA)比值对急性ST段抬高型心肌梗死(STEMI)患者PCI术后冠状动脉无复流的预测价值.方法:选取98 例急性STEMI患者作为研究对象,按术后心肌梗死溶栓试验(TIMI)血流分级将患者分为无复流组(n=25)与复流组(n=73).PCI术前,检测患者血清hs-CRP、PA水平,并计算hs-CRP/PA比值.采用Lo-gistic回归模型分析PCI术后冠状动脉无复流的影响因素,采用受试者工作特征(ROC)曲线评价hs-CRP/PA比值对冠状动脉无复流的预测价值.结果:相比于复流组,无复流组术前LVEF、cTnI、BNP、hs-CRP及hs-CRP/PA比值更高(P<0.05),发病至再灌注时间更长(P<0.05),血清PA水平更低(P<0.05).Logistic回归分析表明,术前LVEF、hs-CRP、PA及hs-CRP/PA比值均是PCI术后冠脉无复流的独立相关因素(P<0.05).ROC曲线分析显示,hs-CRP/PA比值预测急性STEMI患者PCI术后冠状动脉无复流的AUC为0.802,高于hs-CRP的0.707 和PA的0.642(P<0.05);当截断值>28.5 时,hs-CRP/PA比值预测的敏感度为88.0%,特异度为68.5%.结论:术前血清hs-CRP/PA比值是急性STEMI患者术后冠状动脉无复流的独立预测因子,相比于单一指标可较好识别冠状动脉无复流高危患者.

Objective:To investigate the predictive value of high-sensitivity C-reactive protein/prealbumin(hs-CRP/PA)ratio for coronary no-reflow after PCI in patients with acute ST-segment elevation myocardial infarction(STEMI).Methods:A total of 98 pa-tients with acute STEMI were selected.The patients were divided into no-reflow group(n=25)and reflow group(n=73)according to the postoperative thrombolysis in myocardial infarction(TIMI)blood flow classification.Before PCI,the levels of serum hs-CRP and PA were detected,and the ratio of hs-CRP/PA was calculated.Logistic regression model was used to analyze the influencing factors of coro-nary no-reflow after PCI,and the receiver operating characteristic(ROC)curve was used to evaluate the predictive efficacy of hs-CRP/PA ratio on coronary no-reflow.Results:Compared with the reflow group,the serum PA level in the no-reflow group was lower(P<0.05),and the LVEF,cTnI,BNP,hs-CRP and hs-CRP/PA ratio were higher(P<0.05).Logistic regression analysis showed that preoperative LVEF,hs-CRP,PA and hs-CRP/PA ratio were independent related factors of coronary no-reflow after PCI(P<0.05).ROC curve analysis showed that the AUC of hs-CRP/PA ratio in predicting coronary no-reflow after PCI in patients with acute STEMI was 0.802,which was higher than that of hs-CRP(AUC was 0.707)and PA(AUC was 0.642,P<0.05).When the cutoff value was greater than 28.5,the sensitivity of hs-CRP/PA ratio was 88.0%and the specificity was 68.5%.Conclusion:Preoperative serum hs-CRP/PA ratio is an independent predictor of postoperative coronary no-reflow in patients with acute STEMI.Compared with a single in-dicator,it can better identify patients with high risk of coronary no-reflow.

李相权;于宗良;张梦遥;王俊锋;王腾;陶宁超;张梓桑

昆山市第一人民医院心血管内科,江苏 苏州 215300

临床医学

急性ST段抬高型心肌梗死高敏C反应蛋白前白蛋白经皮冠状动脉介入治疗无复流

Acute ST segment elevation myocardial infarctionHigh-sensitivity C-reactive proteinPrealbuminPercutaneous coronary interventionNo reflow

《川北医学院学报》 2024 (007)

888-891 / 4

国家自然科学基金项目(81700737)

10.3969/j.issn.1005-3697.2024.07.005

评论